The estimated Net Worth of Stephen Barat is at least $912 dollars as of 8 June 2023. Dr Barat owns over 888 units of HTG Molecular Diagnostics Inc stock worth over $202 and over the last 2 years he sold HTGM stock worth over $710.
Dr has made over 1 trades of the HTG Molecular Diagnostics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 888 units of HTGM stock worth $710 on 8 June 2023.
The largest trade he's ever made was selling 888 units of HTG Molecular Diagnostics Inc stock on 8 June 2023 worth over $710. On average, Dr trades about 444 units every 0 days since 2023. As of 8 June 2023 he still owns at least 421 units of HTG Molecular Diagnostics Inc stock.
You can see the complete history of Dr Barat stock trades at the bottom of the page.
Dr. Stephen A. Barat Ph.D. is the Sr. VP of Therapeutics at HTG Molecular Diagnostics Inc.
Stephen's mailing address filed with the SEC is C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON, AZ, 85706.
Over the last 10 years, insiders at HTG Molecular Diagnostics Inc have traded over $5,630,772 worth of HTG Molecular Diagnostics Inc stock and bought 1,019,150 units worth $14,128,765 . The most active insiders traders include Plc Gsk, Holdings A/S Novo e Laurence W Lytton. On average, HTG Molecular Diagnostics Inc executives and independent directors trade stock every 64 days with the average trade being worth of $28,039. The most recent stock trade was executed by Stephen Barat on 8 June 2023, trading 888 units of HTGM stock currently worth $710.
about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.
HTG Molecular Diagnostics Inc executives and other stock owners filed with the SEC include: